Citadel Advisors’s Lifestance Health LFST Stock Holding History
Bought
Maintained
Sold
Other funds holding LFST
TGA
SP
VPM
VCM
SPIG
Citadel Advisors's LFST Position: Q1 2026 in Review
Citadel Advisors increased its Lifestance Health (LFST) stake by 9,568% in Q1 2026, buying an estimated $26.5M and bringing the position to 3,850,026 shares worth $24.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2087.
Citadel Advisors first reported a position in LFST in Q2 2021 and has held it in 19 quarters since. 229 funds tracked by Wall St. Rank hold LFST as of Q1 2026.
- Citadel Advisors held 3,850,026 shares of Lifestance Health worth $24.5M as of Q1 2026.
- Citadel Advisors bought 3,810,205 Lifestance Health shares in Q1 2026, an estimated $26.5M.
- Lifestance Health made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #2087 holding.
- Citadel Advisors first reported a position in Lifestance Health in Q2 2021 and has held it in 19 quarters since.
- 229 funds tracked by Wall St. Rank held Lifestance Health as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.